Home > Boards > US OTC > Delisted >

MedClean Technologies, Inc.(fka MCLN)

RSS Feed
Add Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 4/4/2017 9:48:04 AM - Followers: 235 - Board type: Free - Posts Today: 0





MedClean Technologies, Inc. is a provider of innovative technology and services for the onsite treatment and disposal of regulated medical waste. MedClean's flagship MedClean® Series systems are fully integrated, turnkey technology solutions that enable hospitals and other healthcare providers to safely, efficiently, and cost-effectively convert bio-hazardous regulated medical waste into sterile, unrecognizable material suitable for disposal as municipal solid waste. MedClean was founded in 1997 with corporate headquarters, research and development and distribution facilities located in Bethel, Connecticut. 


(Click on link below to view a must see video.)








MedClean Technologies, Inc. Awarded MedAssets Supply Chain Systems Contract

Thu Mar 26, 2009 8:00am EDT 


MedClean to Offer RMW Solutions to MedAssets' GPO Customer Hospitals


MedAssets (Nasdaq: MDAS) partners with healthcare providers to improve their 

financial strength by implementing integrated spend management and revenue

cycle solutions that help control cost, improve margins and cash flow,

increase regulatory compliance, and optimize operational efficiency. MedAssets

serves more than 125 health systems, 3,300 hospitals and 30,000 non-acute care

healthcare providers.



(MedAssets Trades on the NASDAQ as MDAS at over $20.00+ per share.)




MedClean Technologies, Inc. Approved in New Jersey

Garden State Hospitals Can Now Enjoy MedClean Guaranteed Saving Program

Approval Follows Joint Authorization Process by NJ Department of Environmental
Protection and NJ Department of Health and Senior Services






Part 1



Part 2











MedClean Technologies sets the standard for efficacy testing and validation through an ongoing commitment that has resulted in the most extensive body of work in the industry. The MedClean System meets and exceeds the most demanding standards throughout all 50 states. Our work in this area has yielded a protocol that includes significant proprietary intellectual property and is the subject of a United States patent. All MedClean efficacy testing and protocol development is conducted using actual RMW from healthcare institutions to mirror real world operations.

MedClean Technologies is committed to ongoing research and development in this area and to close collaboration with industry experts to provide continuous enhancement of its Best Practices.  







System Components







 Medcleantechnologies, Inc. Partnerships: http://www.medcleantechnologies.com/partners style="font-size: medium;">









Per Yahoo & SEC Filings:



Outstanding Shares (OS) = 809,743,450  as of Dec 2010

Restricted Shares = 293.43

Float = 588.34M 

Authorized Shares (AS) = 3.5B



Management Team





Jay S. Bendis

Chairman of the Board of Directors

Mr. Bendis was appointed as Chairman of the Board of the Company effective March 31, 2011. Mr. Bendis has been President of Transfer Technology Consultants during the past 20 years specializing in transferring emerging life science product concepts from design to commercialization in both domestic and international markets. He was President and CEO of Clinical Analysis Corp., which has developed a hand-held diagnostic system for patient point-of-care testing. He was Managing Partner in the Crystal Corridor Group which worked with Kent State University's Liquid Crystal Institute in facilitating liquid crystal technology. He was Executive Vice President of American BioMedica Corp, which develops, manufacturers and markets immunoassay diagnostic test kits for the workplace, correctional and clinical markets. He was President and Co-founder of Emerging Technology Systems which is a research and development company consisting of engineers specializing in developing new medical devices. His prior management positions had been with XANAR Laser Corp, a division of Johnson & Johnson as the National Sales Manager and Sales and Marketing Manager for the IVAC Corp., a division of Eli Lilly and had sales and management experience with XEROX. He was also a member of the Edison BioTechnology Center Advisory Council for the State of Ohio and presently serves on the Board of Directors of several privately and publicly held companies.



David J. Laky

President and Chief Executive Officer

Mr. Laky was appointed to the positions of President and Chief Executive Officer of the Company effective November 9, 2009. Prior to such appointment Mr. Laky was the Company's Senior Vice President of Client Services and Technology since September 2008. Mr. Laky joined the Company from eResearch Technology, Inc. where from 2005 to 2008 he was General Manager & Vice President of eClinical Group. He served eRT as VP of Professional Services from 1999 to 2005.




Cheryl K. Sadowski

Chief Financial Officer

Ms. Sadowski was appointed to the positions of Chief Financial Officer of the Company effective August 4, 2009. Prior to such appointment Ms. Sadowski was the Company's Vice-President and Controller since October 2008. From February 1994 until October 2008 she held several positions at eResearchTechnology, Inc. in Bridgewater, New Jersey, including Vice President, Business Management and Senior Director, Business Management, where she was responsible for budgeting, forecasting, financial systems and analysis for the Professional Services, Project Management, Customer Care, Research & Development, IT and Cardiac Safety Divisions. She also handled the facilities management and administration for the Bridgewater office.




John R. Accardi

Senior Vice President of Sales/Business Development

Mr. Accardi was named Senior Vice President of Sales/Business Development in September, 2008. Prior, he was with Oracle Corporation/Siebel Systems, where he was responsible for a $40 million line of business and led sales efforts for the financial services and insurance markets in the southeast region and, earlier, served as Senior Director of Siebel's North American Reseller Network. Previously, he served as Vice President of Worldwide Sales for Rasterex, a global provider of software and services extending the value of Auto-Cad solutions. At Rasterex, Mr. Accardi drove $15 million in first year revenue and reversed an operating loss to a profit during the same period. Previously, he served in executive management capacities at systems integrator Gary Brown & Associates and applications provider Computron Software, Inc., Ross Systems and WANG Laboratories.





MCLN Contact Info


MedClean Technologies, Inc
3 Trowbridge Drive
Bethel, CT 06801
Phone: 203-798-1080
Fax: 203-798-0147
Web Site: http://www.medcleantechnologies.com/




Daily View


Weekly View





PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
#35151   did you read all posts? and see ronshappy 04/04/17 09:48:03 AM
#35150   Thanks for the clarification. Lets hope pack10 05/18/15 09:32:17 AM
#35149   The company can be saved (as well as launch3 05/16/15 11:24:51 AM
#35148   Thanks, pack10 05/16/15 10:26:49 AM
#35147   Got a few PM's asking for clarification. Essentially, launch3 05/15/15 04:38:14 PM
#35146   MCLN update: Private offering for accredited investors. Interested launch3 05/15/15 03:52:45 PM
#35145   You can kiss MCLN goodbye. Its been revoked. elkonig 05/15/15 03:44:33 PM
#35144   is this officially over? goose3 05/14/15 11:01:53 PM
#35143   I wonder why the SEC only gave them pack10 05/14/15 09:54:04 AM
#35142   now it's really over Slyder75 05/13/15 06:24:23 PM
#35141   MCLN revoked: Renee 05/13/15 09:44:29 AM
#35140   I noticed that. 134M shares for CEO, 57M launch3 04/09/15 10:34:28 AM
#35139   The new CEO is getting all the shares pack10 04/09/15 10:27:56 AM
#35138   This is the first trade i've seen since pack10 04/07/15 04:49:50 PM
#35137   One tiny trade goes thru each day since launch3 04/07/15 03:46:02 PM
#35136   200 shares trade and the pps stay even???????? pack10 04/07/15 12:01:35 PM
#35135   We're still hanging on by the skin of pack10 04/04/15 10:24:26 AM
#35134   8K released. New management. Not over yet. launch3 04/01/15 12:09:28 PM
#35133   MCLN SEC Admin Law Judge Initial Decision to Renee 03/31/15 05:07:09 PM
#35132   The website was taken down. The default placeholder launch3 03/30/15 12:46:26 PM
#35131   Check out the re-vamped Medclean website yznhimr 03/30/15 12:16:47 PM
#35130   This company is now traded on the grey sheets. pack10 03/25/15 09:20:57 AM
#35129   My open order was cancelled, was MCLN delisted? Drzucco 03/25/15 06:48:40 AM
#35128   According to the CEO, we are supposed to launch3 03/24/15 09:58:47 AM
#35127   Now trading on the grey market pack10 03/24/15 09:47:58 AM
#35126   MCLN: SEC Admin Law Judge Order: ***Failure to respond!! Renee 03/18/15 09:35:56 AM
#35125   Thanks, at least something. pack10 03/13/15 12:49:03 PM
#35124   Got a reply... Expect to see something either launch3 03/13/15 12:40:35 PM
#35123   No recent statements or news on the SEC launch3 03/12/15 05:48:43 PM
#35122   As expected we hear nothing. pack10 03/12/15 03:22:28 PM
#35121   When we will trade again ? fogao 2012 03/12/15 08:39:01 AM
#35120   Thanks Pack. I emailed John on monday and launch3 03/07/15 11:11:07 AM
#35119   Not 100% certainty, but pretty darn close to pack10 03/07/15 10:12:18 AM
#35118   Thanks pack. I thought you might say that. launch3 03/06/15 10:32:04 AM
#35117   I'll try and be at my computer after pack10 03/06/15 10:30:04 AM
#35116   Any word on MCLN? launch3 03/06/15 10:26:25 AM
#35115   Thanks for your reply. It has pack10 03/06/15 10:23:17 AM
#35114   Hows that crystal ball? pack10 03/05/15 05:12:11 PM
#35113   Either way, you will win. ttxxhorns 02/27/15 12:38:33 PM
#35112   If they don't file an answer, when this launch3 02/27/15 12:12:51 PM
#35111   Two possiblities. ttxxhorns 02/27/15 12:01:22 PM
#35110   We will all know something very shortly. They launch3 02/27/15 11:52:22 AM
#35109   Somebody knows something! ttxxhorns 02/27/15 10:17:20 AM
#35108   Well, at least now we will start to launch3 02/25/15 09:51:39 AM
#35107   MCLN SEC Suspension for Financials delinquencies: Renee 02/25/15 09:32:25 AM
#35106   Are you going to every board on that pack10 02/23/15 03:27:27 PM
#35105   MCLN is severely delinquent in filing their Financials Renee 02/22/15 10:56:20 AM
#35104   Well....that makes the OS 24M ......fwtfw.......et z Zardiw 02/09/15 09:48:26 AM
#35103   Yes they did in April 2013. ASK 02/09/15 07:21:11 AM
#35102   They ever do that 1-100 RS they filed Zardiw 02/08/15 11:04:08 PM